Industry › Healthcare & Pharm

Press Releases

Avance Clinical 慶祝GlobalReady成功　超過40家生物技術客戶進入計劃

Jan 12, 2023 07:00 HKT/SGT

Avance Clinical 庆祝GlobalReady成功　超过40家生物技术客户进入计划

Jan 12, 2023 07:00 HKT/SGT

HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)

Jan 11, 2023 21:00 HKT/SGT

Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program

Jan 11, 2023 15:00 HKT/SGT

Prenetics旗下的行动基因的ACTOnco® IVD产品获得FDA许可成为首家就适用于所有实体肿瘤的癌症基因检测取得许可的亚洲公司

Jan 11, 2023 11:21 HKT/SGT

Prenetics旗下的行動基因的ACTOnco® IVD產品獲得FDA許可成為首家就適用於所有實體腫瘤的癌症基因檢測取得許可的亞洲公司

Jan 11, 2023 11:20 HKT/SGT

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

Jan 11, 2023 11:19 HKT/SGT

君聖泰HTD1801治療非酒精性脂肪性肝炎（NASH）的臨床IIb 期研究（CENTRICITY研究）完成首例患者給藥

Jan 11, 2023 08:01 HKT/SGT

君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药

Jan 11, 2023 08:00 HKT/SGT

医思健康向赴港旅客提供复必泰二价疫苗服务

Jan 10, 2023 18:03 HKT/SGT

醫思健康向赴港旅客提供復必泰二價疫苗服務

Jan 10, 2023 18:02 HKT/SGT

China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate

Jan 10, 2023 16:33 HKT/SGT

Malaysian Genomics Explores R&D Collaboration with SIRIM

Jan 09, 2023 14:00 HKT/SGT

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

Jan 05, 2023 18:00 HKT/SGT

君聖泰完成1.07 億美元C/C+輪融資，加速推進在研管線的全球開發、商業化和商務拓展

Jan 05, 2023 08:01 HKT/SGT

君圣泰完成1.07 亿美元C/C+轮融资，加速推进在研管线的全球开发、商业化和商务拓展

Jan 05, 2023 08:00 HKT/SGT

四环医药（0460.HK）：惠升生物成功完成A +轮融资，加速糖尿病及并发症领域布局

Jan 04, 2023 09:57 HKT/SGT

四環醫藥（0460.HK）：惠升生物成功完成A +輪融資，加速糖尿病及併發症領域佈局

Jan 04, 2023 09:56 HKT/SGT

Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical Successfully Completes A+ Round of Financing, Accelerating the Layout of Diabetes and Complications

Jan 04, 2023 09:55 HKT/SGT

Beauty Farm Medical and Health Industry Inc. Announces Proposed Listing on the Main Board of SEHK, Offer price at HK$19.32 per share

Dec 30, 2022 10:18 HKT/SGT